TEVA stock fundamentals - financials as reported

Financials As Reported

accession Number 0001193125-23-140697
accounts Receivable Net Current 3,435,000,000
accumulated Other Comprehensive Income Loss Net Of Tax --2,701,000,000
amendment Flag false
assets 43,456,000,000
assets Current 11,501,000,000
cash And Cash Equivalents At Carrying Value 2,143,000,000
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,176,000,000
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --658,000,000
cik 818,686
city Area Code +972 (3)
common Stock Par Or Stated Value Per Share 0.1
common Stock Shares Authorized 2,495,000,000
common Stock Shares Issued 1,226,000,000
comprehensive Income Net Of Tax --69,000,000
cost Of Goods And Services Sold 2,079,000,000
current Fiscal Year End Date --12-31
date Filed 2023-05-10
document Fiscal Period Focus Q1
document Fiscal Year Focus 2,023
document Period End Date 2023-03-31
document Transition Report false
document Type 10-Q
earnings Per Share Basic -0.18
earnings Per Share Diluted -0.18
entity Address Address Line 1 124 Dvora HaNevi’a St.
entity Address City Or Town Tel Aviv
entity Address Postal Zip Code 6,944,020
entity Central Index Key 818,686
entity Current Reporting Status Yes
entity Emerging Growth Company false
entity File Number 001-16174
entity Filer Category Large Accelerated Filer
entity Incorporation State Country Code L3
entity Interactive Data Current Yes
entity Name TEVA PHARMACEUTICAL INDUSTRIES LTD
entity Registrant Name TEVA PHARMACEUTICAL INDUSTRIES LIMITED
entity Shell Company false
entity Small Business false
entity Tax Identification Number 00-0000000
gross Profit 1,582,000,000
income Tax Expense Benefit --19,000,000

inventory Net 4,118,000,000
irs Number 0
liabilities 34,844,000,000
liabilities And Stockholders Equity 43,456,000,000
liabilities Current 10,411,000,000
liabilities Noncurrent 24,433,000,000
local Phone Number 914-8213
long Term Debt Current 1,000,000,000
net Cash Provided By Used In Financing Activities --706,000,000
net Cash Provided By Used In Investing Activities 181,000,000
net Cash Provided By Used In Operating Activities --145,000,000
net Income Loss --205,000,000
nonoperating Income Expense --260,000,000
operating Income Loss 2,000,000
operating Lease Liability Noncurrent 345,000,000
operating Lease Right Of Use Asset 420,000,000
other Assets Current 542,000,000
other Assets Noncurrent 450,000,000
other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 120,000,000
other Liabilities Current 1,000,000,000
other Liabilities Noncurrent 3,869,000,000
payments For Proceeds From Other Investing Activities 1,000,000
payments To Acquire Businesses Net Of Cash Acquired 0
payments To Acquire Property Plant And Equipment 139,000,000
period End 1,680,220,800,000
period Start 1,672,531,200,000
proceeds From Payments For Other Financing Activities --5,000,000
property Plant And Equipment Net 5,751,000,000
repayments Of Long Term Debt 3,152,000,000
report Link https://www.sec.gov/Archives/edgar/data/818686/000119312523140697/d464631d10q_htm.xml
retained Earnings Accumulated Deficit --13,086,000,000
revenue From Contract With Customer Excluding Assessed Tax 3,661,000,000
share Based Compensation 32,000,000
stockholders Equity 7,860,000,000
trading Symbol TEVA
update 1970-01-01
weighted Average Number Diluted Shares Outstanding Adjustment 1,115,000,000
weighted Average Number Of Diluted Shares Outstanding 1,115,000,000
weighted Average Number Of Shares Outstanding Basic 1,115,000,000
id REPORTED_FINANCIALS
key TEVA
subkey 10-Q
date 2023-05-10
updated 2023-05-11